Israeli - Kiingereza - Ministry of Health

trima israel pharmaceutical products maabarot ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - rasagiline - tablet - 1mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

hbs healthcare ltd - rasagiline - tablet - 1mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk - rasagiline - tablet - 1mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - rasagiline - tablet - 1mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

rivopharm (uk - rasagiline - tablet - 1mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - rasagiline - tablet - 1mg

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: purified talc; maize starch; citric acid monohydrate; microcrystalline cellulose; stearic acid; colloidal anhydrous silica; pregelatinised maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: citric acid monohydrate; colloidal anhydrous silica; stearic acid; purified talc; pregelatinised maize starch; microcrystalline cellulose; maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Israeli - Kiingereza - Ministry of Health

teva israel ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.